CD274 and neoplasm: The intrinsically immune tolerogenic liver niche may favor the establishment of a multitude of tumor escape mechanisms beyond the upregulation of the PD-(L)1 axis requiring the study of tumor-specific biomarkers and therapeutic strategies in CCAs.